BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 21741160)

  • 1. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.
    Guðmundsson E; Hellborg H; Lundstam S; Erikson S; Ljungberg B;
    Eur Urol; 2011 Nov; 60(5):975-82. PubMed ID: 21741160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
    Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
    Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New cut-off point between T1 and T2 renal cell carcinoma - necessary for a better discriminatory power of the TNM classification.
    Wunderlich H; Dreihaupt M; Schlichter A; Kosmehl H; Reichelt O; Schubert J
    Urol Int; 2004; 72(2):123-8. PubMed ID: 14963352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of locally advanced and metastatic disease in patients with small renal masses.
    Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
    BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node dissection in renal cell carcinoma.
    Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
    Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
    Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
    Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
    Lughezzani G; Jeldres C; Isbarn H; Perrotte P; Shariat SF; Sun M; Widmer H; Arjane P; Peloquin F; Pharand D; Patard JJ; Graefen M; Montorsi F; Karakiewicz PI
    J Urol; 2009 Oct; 182(4):1287-93. PubMed ID: 19683281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
    Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
    Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histopathological heterogeneity of small renal cell carcinoma.
    Wunderlich H; Schlichter A; Kosmehl H; Schubert J
    Anticancer Res; 1999; 19(2C):1497-500. PubMed ID: 10365131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.
    Remzi M; Ozsoy M; Klingler HC; Susani M; Waldert M; Seitz C; Schmidbauer J; Marberger M
    J Urol; 2006 Sep; 176(3):896-9. PubMed ID: 16890647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic variables to predict cancer-related death in incidental renal tumours.
    Bensalah K; Pantuck AJ; Crepel M; Verhoest G; Méjean A; Valéri A; Ficarra V; Pfister C; Ferrière JM; Soulié M; Cindolo L; De La Taille A; Tostain J; Chautard D; Schips L; Zigeuner R; Abbou CC; Lobel B; Salomon L; Lechevallier E; Descotes JL; Guillé F; Colombel M; Belldegrun AS; Patard JJ
    BJU Int; 2008 Nov; 102(10):1376-80. PubMed ID: 18727618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.
    Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J
    Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of lymph node dissection in renal cell carcinoma.
    Matsuyama H; Hirata H; Korenaga Y; Wada T; Nagao K; Yamaguchi S; Yoshihiro S; Naito K
    Scand J Urol Nephrol; 2005; 39(1):30-5. PubMed ID: 15764268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.